Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2000
10/18/2000EP0467932B1 Urokinase-type plasminogen activator receptor
10/18/2000CN2401562Y High pneumatic gene gun
10/18/2000CN2401561Y Magazine holder and magazine for high pneumatic gene gun
10/18/2000CN1270638A DNA bracketing locus compatible standards for electrophoresis
10/18/2000CN1270637A Isolation of a novel senescence-factor gene, P23
10/18/2000CN1270636A DNA sequence coding for a hydroxyphenylpyruvate dioxygenase and overproduction thereof in plants
10/18/2000CN1270635A Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these protein
10/18/2000CN1270634A Vertebrate telomerase genes and proteins and uses thereof
10/18/2000CN1270633A Human chloride ion channel ZSIG44
10/18/2000CN1270632A APPIL-a novel protein with growth effects
10/18/2000CN1270631A Process for producing purine nucleosides via fermentation
10/18/2000CN1270630A Method of treating leukocytes, leukocyte compositions and methods of use thereof
10/18/2000CN1270598A Methods and compounds for analyzing nucleic acids by mass spectrometry
10/18/2000CN1270497A Toxin genes from the bacteria i (xenorhabdus nematophilus) and i (photorhabdus luminescens)
10/18/2000CN1270228A Oligonucleolide primers for effectively inserse recording HCV RNA and use thereof
10/18/2000CN1270225A Electrotransfer technique of Epo gene
10/18/2000CN1270224A DNA molecules of aminopeptidase with new code and production of the aminopeptidase
10/18/2000CN1270222A Human coenzyme I subunit isomer protein and its coding sequence
10/18/2000CN1270221A Human adenosine triphosphatase subunit protein and its coding sequence
10/18/2000CN1270220A Human protein related to VB12 and its coding sequence
10/18/2000CN1057568C Process for preparation of D-alpha-amino acids
10/18/2000CN1057567C Colone and/or express vectors, process of production and use thereof
10/18/2000CN1057566C Method for producing transgenosis kelp
10/18/2000CN1057565C Lumbrical fibrinolysin gene nucleotide series, and method for clone of same
10/18/2000CN1057564C Microbe capable of producing active recombinant phycabiliprotein and its preparing method
10/18/2000CN1057535C Process for producing hydrophobic polypeptides proteins or peptides
10/18/2000CN1057534C Erythropoietin analogs
10/18/2000CN1057533C Method for producing clostridium perfringers vaccines
10/18/2000CN1057532C Process for purifying hepatitis B viral surface antigen comprising PRES2 peptide
10/17/2000US6133507 Specific nucleotide sequence which codes for a chitin binding protein of rhizomes of urtica dioica; for transgenic plants with insecticidal properties in leaves
10/17/2000US6133506 Keto-acyl-(ACP) reductase promoter from cuphea lanceolata
10/17/2000US6133505 Phytopathogenic geminivirus resistant transgenic plants and seeds and methods for obtaining same by introduction of mutated C1 gene
10/17/2000US6133504 Transgenic plant tolerant to sodium chloride stress containing a foreign dna encoding a gene for reductase enzyme operably linked to a heterologous promoter
10/17/2000US6133503 Mammalian artificial chromosomes and methods of using same
10/17/2000US6133502 Monocyte chemoattractant protein and its receptor transgenic animal
10/17/2000US6133438 Alkylating unblocked cytidine to form 2'-o-alkylated cytidine, blocking the 5'-hydroxyl moiety, and phosphitylating the 3'-position
10/17/2000US6133437 Antisense nucleic acid which is complementary to specific human and mouse nucleotide sequences and suppresses the biological activity of inhibitor of apoptosis in vitro; anticarcinogenic agents
10/17/2000US6133435 AGL15 sequences in transgenic plants
10/17/2000US6133428 Antibody which binds to an epitope of a specific amino acid sequence
10/17/2000US6133427 Anti-human calcitonin monoclonal antibodies and an immunoassay utilizing said antibodies
10/17/2000US6133423 Don-1 gene and polypeptides and uses therefor
10/17/2000US6133422 Purified protein having defined amino acid sequence; anticoagulants
10/17/2000US6133421 Polypeptides and polypeptide subunits of a stereospecific nitrile hydratase enzyme
10/17/2000US6133419 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
10/17/2000US6133418 Synthetic peptide inhibitors of HIV transmission
10/17/2000US6133417 Enzyme catalyzes conversion of amino acid to corresponding n-hydroxyamino acid and then into corresponding oxime; for transgenic plants resistant to insects, acarids, or nematodes or plants with improved nutritive value
10/17/2000US6133416 Inhibition of cell growth by an anti-proliferative factor
10/17/2000US6133246 Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
10/17/2000US6133245 Introducing into cell an inducible tissue specific antisense dna construct comprising coding sequence of inducible tissue specific gene product into which dna sequence antisense to dna sequence of gene targeted for regulation has been inserted
10/17/2000US6133243 Administering to tumor a complex consisting of liposomal viral dna, said viral dna being purified adenoviral dna not in an expression vector and lacking expressed viral oncoprotein that binds to functional p53 tumor suppressor protein
10/17/2000US6133242 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes
10/17/2000US6133232 Protein or fragment having neurotrophic, growth or differentiation factor activity in xenopus embryos
10/17/2000US6133035 Transforming embryogenic material with agrobacterium containing gene of interest and regenerating into a plant
10/17/2000US6133034 Methods and compositions related to the production of trehalose
10/17/2000US6133032 Antisense modulation of PI3 kinase p110 beta expression
10/17/2000US6133031 Antisense inhibition of focal adhesion kinase expression
10/17/2000US6133029 Replication defective viral vectors for infecting human cells
10/17/2000US6133028 For gene therapy
10/17/2000US6133027 For production of cytotoxic gene products for gene therapy; includes an inducible promoter linked to gene of interest and a promoter linked to a sequence encoding a multi-chimeric transactivating factor having several ligand binding domains
10/17/2000US6133026 Condensed plasmid-liposome complex for transfection
10/17/2000US6133025 Nucleic acid for episomal replication in mammalian cells; includes a cis-acting origin of replication sequence and the nuclear antigen 1 sequence linked to a promoter; for gene therapy
10/17/2000US6133024 Recombinant vector which codes for an rna capable of forming a triple helix with target nucleic acid; for transcription of the rna in target cells
10/17/2000US6133023 Expression vector including a promoter region controlled by environmental factors such as ph, growth temperature, oxygen content, and others and at least one restriction site; for increased gene expression/production of vaccines
10/17/2000US6133017 Attenuated strain of Leishmania
10/17/2000US6133016 Sphingomonas biodesulfurization catalyst
10/17/2000US6133014 Maleate isomerase gene
10/17/2000US6133012 Thermostable acyl peptide hydrolase and gene encoding the same
10/17/2000US6133011 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
10/17/2000US6133010 Chlamysin B antibacterial protein, a protein gene for and an expression system for same
10/17/2000US6133009 Type II Restriction endonuclease, HpyCH4V, obtainable from helicobacter pylori CH4 and a process for producing the same
10/17/2000US6133008 Method for cloning and producing the TfiI Restriction endonuclease in E. coli
10/17/2000US6133007 Phosphodiesterase 8A
10/17/2000US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections
10/17/2000US6133005 Enzymatic protein; for the treatment of nervous system disorders associated with thamine vitamin deficiency
10/17/2000US6132999 Nucleotide sequences coding threonine operon; for the fermentation of threonine
10/17/2000US6132997 Converting to complementary dna; transcribing with rna polymerase and ribonucleotide into antisense rna
10/17/2000US6132992 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
10/17/2000US6132991 Human interleukin-3 (IL-3) variant fusion proteins
10/17/2000US6132990 Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
10/17/2000US6132989 Methods and compositions for enhanced stability of non-adenoviral DNA
10/17/2000US6132988 Nucleotide sequence coding a nervous system protein; for diagnosis of nerve degredation; for detection of modulators of activin activity
10/17/2000US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis
10/17/2000US6132983 Microorganismal protein with enzymatic activity associated with luminescence
10/17/2000US6132981 Screening for human incubation with radioactivity; scanning erythrocytes for transferrin receptors, and comparing to control cell that have not been incubated with radoactivity
10/17/2000US6132980 Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes
10/17/2000US6132973 Nucleotide sequence coding protein associated with gene expression; for the diagnosis, prevention, and treatment of defects associated with cell proliferation
10/17/2000US6132972 Screening for nucleic acids in sample; mix binding protein, nucleic acid probe and target nucleotide sequence in sample, digest both nucleotide sequence complementary to target and binding protein, hybridize oligonucleotide and detect signal
10/17/2000US6132970 Rearranging nucleotide sequences; extending chains of nucleotide sequence with regions of both homogeneity and heterogeneity in multiple cycles, screening rearranged nucleotide sequences to detect desired properties
10/17/2000US6132969 Methods for testing biological network models
10/17/2000US6132967 Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1)
10/17/2000US6132966 Enzymatic nucleic acid which specifically prevents viral replication; for the treatment of transformed hepatocytes and suppression of viral infection humans, animals and primates
10/17/2000US6132965 Detecting premature atherosclerosis in humans; screening humans for amplified levels of serum homocysteine and comparing to control
10/17/2000US6132963 Nucleotide sequences coding modulator protein; for the detection of modulation of signal transduction
10/17/2000US6132962 Plasmid coding ribozyme; for the prevention of viral infection
10/17/2000US6132960 Envelope polypeptide; for the detection of plant parasite
10/17/2000US6132776 Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing
10/17/2000US6132734 Cloning of mite allergens
10/17/2000US6132732 Parvovirus capsids
10/17/2000US6132731 Murine leukemia virus vectors
10/17/2000US6132728 Hedgehog-derived polypeptides
1 ... 3170 3171 3172 3173 3174 3175 3176 3177 3178 3179 3180 3181 3182 3183 3184 3185 3186 3187 3188 3189 3190 ... 4023